Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly and Co | Buenos Aires | Healthcare | Pharmaceuticals | ARS 1,102.54T | 39.4x | 0.42 | ARS 23,470 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Johnson & Johnson DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 785.63T | 27.3x | -7.06 | ARS 23,100 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Johnson Johnson DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 785.63T | 27.3x | 0.23 | ARS 2,500 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Abbvie | Buenos Aires | Healthcare | Pharmaceuticals | ARS 500.81T | 88.3x | -70.78 | ARS 30,380 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| AstraZeneca PLC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 421.91T | 30.6x | 0.68 | ARS 72,975 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Novartis DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 396.95T | 21.3x | 0.97 | ARS 55,375 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Merck & Co DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 396.74T | 16.2x | 2.03 | ARS 34,400 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| UnitedHealth Group | Buenos Aires | Healthcare | Healthcare Providers & Services | ARS 387.98T | 23.8x | -1.61 | ARS 13,830 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Thermo Fisher Scientific | Buenos Aires | Healthcare | Healthcare Equipment & Supplies | ARS 268.41T | 30x | 3.99 | ARS 35,180 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Amgen | Buenos Aires | Healthcare | Pharmaceuticals | ARS 255.44T | 24.2x | 0.28 | ARS 16,820 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Abbott Laboratories | Buenos Aires | Healthcare | Healthcare Equipment & Supplies | ARS 240.29T | 27.4x | -0.53 | ARS 36,800 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Gilead Sciences | Buenos Aires | Healthcare | Pharmaceuticals | ARS 235.68T | 20.4x | 0.01 | ARS 50,650 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Intuitive Surgical DRC | Buenos Aires | Healthcare | Healthcare Equipment & Supplies | ARS 225.94T | 61.4x | 2.57 | ARS 7,645 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Pfizer DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 210.43T | 19.9x | -5.91 | ARS 9,890 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Danaher DRC | Buenos Aires | Healthcare | Healthcare Equipment & Supplies | ARS 190.49T | 40.6x | -8.48 | ARS 5,345 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Bristol-Myers Squibb DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 160.57T | 16.6x | 0.09 | ARS 28,140 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| GSK plc DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 157.05T | 15.2x | 0.12 | ARS 21,050 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Vertex Pharmaceuticals DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 152.63T | 29.8x | 0.03 | ARS 6,350 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Medtronic | Buenos Aires | Healthcare | Healthcare Equipment & Supplies | ARS 151.64T | 24.5x | 2.59 | ARS 31,640 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| CVS Health DRC | Buenos Aires | Healthcare | Healthcare Providers & Services | ARS 130.56T | 54.2x | -0.91 | ARS 7,435 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Cardinal Health | Buenos Aires | Healthcare | Pharmaceuticals | ARS 67.72T | 30.4x | 1.02 | ARS 102,300 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Koninklijke Philips DRC | Buenos Aires | Healthcare | Healthcare Equipment & Supplies | ARS 37.70T | 26.2x | 0.12 | ARS 8,415 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Biogen AR | Buenos Aires | Healthcare | Pharmaceuticals | ARS 35.99T | 20.3x | -0.95 | ARS 20,230 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Moderna DRC | Buenos Aires | Healthcare | Pharmaceuticals | ARS 29.23T | -7.5x | -0.33 | ARS 4,147.50 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Tempus AI DRC | Buenos Aires | Healthcare | Biotechnology & Medical Research | ARS 13.73T | -34.7x | -0.47 | ARS 6,775 | 12.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Laboratorios Richmond | Buenos Aires | Healthcare | Pharmaceuticals | ARS 134.85B | 56.8x | -0.63 | ARS 1,670 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Instituto Rosenbusch | Buenos Aires | Healthcare | Pharmaceuticals | ARS 6.90B | -1.7x | ARS 163.50 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |